Established CRO Hooke Laboratories is a privately owned, founder-led preclinical CRO with a strong track record since 2007 and a no-layoff history, signaling stability and reliability for potential repeat business and long-term partnerships.

Market Position Positioned as a leading global-focused rodent in vivo immunology CRO with significant credibility, serving eight of the top ten and fifteen of the top twenty pharmas, indicating strong potential for high-value collaborations and premium service engagements.

Expansion Opportunity Relocation to a larger facility in Salem, NH in Q1 2027 suggests capacity to take on larger projects and increased throughput, enabling sales pitches around scale-up capabilities and expanded service scope.

Full Service Stack Comprehensive offerings from model creation and execution to advanced analytics including RNA-seq, scRNA-seq, bioinformatics, and multiplex immunofluorescence, creating cross-sell opportunities across therapeutic areas and integrated study design consulting.

Quality and Expertise Emphasis on scientific rigor, thoughtful study design, and advisory support for mode of action and study design appeals to sponsors seeking quality assurance, regulatory alignment, and strategic collaboration rather than just execution.